Transforming Medical Technology: The Launch of the Innovative Devices Access Pathway in the UK

By HEOR Staff Writer

September 20, 2023

A New Era of Medical Innovation

The Department of Health and Social Care (DHSC), Health Technology Wales (HTW), the Medicines and Healthcare products Regulatory Agency (MHRA), and several other health organizations have launched the Innovative Devices Access Pathway (IDAP) pilot. This new pathway, backed by £10 million of government funding, aims to fast-track patient access to innovative technologies by providing comprehensive support and advice to innovators and manufacturers.

A Pathway Paved with Potential

The IDAP is more than just a funding program. It’s a vision for the future of healthcare in the UK. The pathway aims to support the rapid development of innovative technologies that can be introduced into the National Health Service (NHS) to address unmet clinical needs. This is not just about getting new products to market quickly, but also ensuring they meet the highest standards of safety, quality, and effectiveness.

The pilot phase of the IDAP has now been launched, with innovators invited to submit Expressions of Interest for access into the pathway. Successful applicants will receive a range of support, including the development of a targeted product roadmap, system navigation advice, and support with Health Technology Assessments (HTA) for product realization and adoption.

The IDAP is open to both commercial and non-commercial innovators of medical technology in the UK and abroad. The submissions for the pilot phase opened on 19 September 2023 and will close on 29 October 2023. The future of healthcare is here, and it’s innovative, inclusive, and incredibly exciting.

Reference url

Recent Posts

Paving the Way for Digital Health Technologies: NICE’s Bold New Strategy for the NHS

By HEOR Staff Writer

October 9, 2025

The National Institute for Health and Care Excellence (NICE) is expanding its technology appraisals programme, and starting April 2026, this will include digital health technologies that are placed on an equal legal footing with medicines in the NHS. This initiative forms part of the NHS 10-year ...
Health Misinformation Autism: The Dangers of Politicized Science in Vaccine and Drug Discourse

By João L. Carapinha

October 7, 2025

The BMJ article “Tylenol, vaccines, and autism: the medical mayhem of the MAGA methodologists” argues that political and ideological actors, notably aligned with the MAGA movement, are promoting health misinformation about autism, vaccines, and paracetamol. They amplify preliminary, misinterprete...
Lurbinectedin SCLC Therapy: FDA Approval and Its Economic Implications

By João L. Carapinha

October 6, 2025

The U.S. Food and Drug Administration (FDA) has recently approved lurbinectedin SCLC therapy in combination with atezolizumab, or with atezolizumab and hyaluronidase-qvfc, for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC). This regulatory decision reflects ...